Affymax, Inc. (NASDAQ:AFFY) is expected to released its fourth quarter earning 2012 on Thursday this week. The company in less than two weeks mortified shareholders after it and along with its licensing partner Takeda Pharmaceuticals declared the voluntary recall of anemia drug Omontys. This would be conference call for Omontys is far more important to…